Global Glucagon Injectable Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Glucagon Injectable market size was valued at US$ million in 2023. With growing demand in downstream market, the Glucagon Injectable is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Glucagon Injectable market. Glucagon Injectable are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Glucagon Injectable. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Glucagon Injectable market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Glucagon Injectable market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Glucagon Injectable market. It may include historical data, market segmentation by Type (e.g., Children, Adults), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Glucagon Injectable market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Glucagon Injectable market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Glucagon Injectable industry. This include advancements in Glucagon Injectable technology, Glucagon Injectable new entrants, Glucagon Injectable new investment, and other innovations that are shaping the future of Glucagon Injectable.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Glucagon Injectable market. It includes factors influencing customer ' purchasing decisions, preferences for Glucagon Injectable product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Glucagon Injectable market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Glucagon Injectable market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Glucagon Injectable market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Glucagon Injectable industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Glucagon Injectable market.
Market Segmentation:
Glucagon Injectable market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Glucagon Injectable market?
What factors are driving Glucagon Injectable market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glucagon Injectable market opportunities vary by end market size?
How does Glucagon Injectable break out type, application?
According to our LPI (LP Information) latest study, the global Glucagon Injectable market size was valued at US$ million in 2023. With growing demand in downstream market, the Glucagon Injectable is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Glucagon Injectable market. Glucagon Injectable are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Glucagon Injectable. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Glucagon Injectable market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Glucagon Injectable market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Glucagon Injectable market. It may include historical data, market segmentation by Type (e.g., Children, Adults), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Glucagon Injectable market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Glucagon Injectable market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Glucagon Injectable industry. This include advancements in Glucagon Injectable technology, Glucagon Injectable new entrants, Glucagon Injectable new investment, and other innovations that are shaping the future of Glucagon Injectable.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Glucagon Injectable market. It includes factors influencing customer ' purchasing decisions, preferences for Glucagon Injectable product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Glucagon Injectable market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Glucagon Injectable market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Glucagon Injectable market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Glucagon Injectable industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Glucagon Injectable market.
Market Segmentation:
Glucagon Injectable market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Children
- Adults
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Fresenius SE & Co. KGaA
- Xeris Pharmaceuticals Inc
- Novo Nordisk A/S
- ILS.Inc
- Amphastar Pharmaceuticals Inc.
- Lilly USA, LLC
- Zealand Pharma A/S.
- Avalon Pharma Pvt. Ltd.
What is the 10-year outlook for the global Glucagon Injectable market?
What factors are driving Glucagon Injectable market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glucagon Injectable market opportunities vary by end market size?
How does Glucagon Injectable break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Glucagon Injectable Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Glucagon Injectable by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Glucagon Injectable by Country/Region, 2019, 2023 & 2030
2.2 Glucagon Injectable Segment by Type
2.2.1 Children
2.2.2 Adults
2.3 Glucagon Injectable Sales by Type
2.3.1 Global Glucagon Injectable Sales Market Share by Type (2019-2024)
2.3.2 Global Glucagon Injectable Revenue and Market Share by Type (2019-2024)
2.3.3 Global Glucagon Injectable Sale Price by Type (2019-2024)
2.4 Glucagon Injectable Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Others
2.5 Glucagon Injectable Sales by Application
2.5.1 Global Glucagon Injectable Sale Market Share by Application (2019-2024)
2.5.2 Global Glucagon Injectable Revenue and Market Share by Application (2019-2024)
2.5.3 Global Glucagon Injectable Sale Price by Application (2019-2024)
3 GLOBAL GLUCAGON INJECTABLE BY COMPANY
3.1 Global Glucagon Injectable Breakdown Data by Company
3.1.1 Global Glucagon Injectable Annual Sales by Company (2019-2024)
3.1.2 Global Glucagon Injectable Sales Market Share by Company (2019-2024)
3.2 Global Glucagon Injectable Annual Revenue by Company (2019-2024)
3.2.1 Global Glucagon Injectable Revenue by Company (2019-2024)
3.2.2 Global Glucagon Injectable Revenue Market Share by Company (2019-2024)
3.3 Global Glucagon Injectable Sale Price by Company
3.4 Key Manufacturers Glucagon Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glucagon Injectable Product Location Distribution
3.4.2 Players Glucagon Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GLUCAGON INJECTABLE BY GEOGRAPHIC REGION
4.1 World Historic Glucagon Injectable Market Size by Geographic Region (2019-2024)
4.1.1 Global Glucagon Injectable Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Glucagon Injectable Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Glucagon Injectable Market Size by Country/Region (2019-2024)
4.2.1 Global Glucagon Injectable Annual Sales by Country/Region (2019-2024)
4.2.2 Global Glucagon Injectable Annual Revenue by Country/Region (2019-2024)
4.3 Americas Glucagon Injectable Sales Growth
4.4 APAC Glucagon Injectable Sales Growth
4.5 Europe Glucagon Injectable Sales Growth
4.6 Middle East & Africa Glucagon Injectable Sales Growth
5 AMERICAS
5.1 Americas Glucagon Injectable Sales by Country
5.1.1 Americas Glucagon Injectable Sales by Country (2019-2024)
5.1.2 Americas Glucagon Injectable Revenue by Country (2019-2024)
5.2 Americas Glucagon Injectable Sales by Type
5.3 Americas Glucagon Injectable Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glucagon Injectable Sales by Region
6.1.1 APAC Glucagon Injectable Sales by Region (2019-2024)
6.1.2 APAC Glucagon Injectable Revenue by Region (2019-2024)
6.2 APAC Glucagon Injectable Sales by Type
6.3 APAC Glucagon Injectable Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Glucagon Injectable by Country
7.1.1 Europe Glucagon Injectable Sales by Country (2019-2024)
7.1.2 Europe Glucagon Injectable Revenue by Country (2019-2024)
7.2 Europe Glucagon Injectable Sales by Type
7.3 Europe Glucagon Injectable Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Glucagon Injectable by Country
8.1.1 Middle East & Africa Glucagon Injectable Sales by Country (2019-2024)
8.1.2 Middle East & Africa Glucagon Injectable Revenue by Country (2019-2024)
8.2 Middle East & Africa Glucagon Injectable Sales by Type
8.3 Middle East & Africa Glucagon Injectable Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glucagon Injectable
10.3 Manufacturing Process Analysis of Glucagon Injectable
10.4 Industry Chain Structure of Glucagon Injectable
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glucagon Injectable Distributors
11.3 Glucagon Injectable Customer
12 WORLD FORECAST REVIEW FOR GLUCAGON INJECTABLE BY GEOGRAPHIC REGION
12.1 Global Glucagon Injectable Market Size Forecast by Region
12.1.1 Global Glucagon Injectable Forecast by Region (2025-2030)
12.1.2 Global Glucagon Injectable Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glucagon Injectable Forecast by Type
12.7 Global Glucagon Injectable Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Fresenius SE & Co. KGaA
13.1.1 Fresenius SE & Co. KGaA Company Information
13.1.2 Fresenius SE & Co. KGaA Glucagon Injectable Product Portfolios and Specifications
13.1.3 Fresenius SE & Co. KGaA Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Fresenius SE & Co. KGaA Main Business Overview
13.1.5 Fresenius SE & Co. KGaA Latest Developments
13.2 Xeris Pharmaceuticals Inc
13.2.1 Xeris Pharmaceuticals Inc Company Information
13.2.2 Xeris Pharmaceuticals Inc Glucagon Injectable Product Portfolios and Specifications
13.2.3 Xeris Pharmaceuticals Inc Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Xeris Pharmaceuticals Inc Main Business Overview
13.2.5 Xeris Pharmaceuticals Inc Latest Developments
13.3 Novo Nordisk A/S
13.3.1 Novo Nordisk A/S Company Information
13.3.2 Novo Nordisk A/S Glucagon Injectable Product Portfolios and Specifications
13.3.3 Novo Nordisk A/S Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novo Nordisk A/S Main Business Overview
13.3.5 Novo Nordisk A/S Latest Developments
13.4 ILS.Inc
13.4.1 ILS.Inc Company Information
13.4.2 ILS.Inc Glucagon Injectable Product Portfolios and Specifications
13.4.3 ILS.Inc Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 ILS.Inc Main Business Overview
13.4.5 ILS.Inc Latest Developments
13.5 Amphastar Pharmaceuticals Inc.
13.5.1 Amphastar Pharmaceuticals Inc. Company Information
13.5.2 Amphastar Pharmaceuticals Inc. Glucagon Injectable Product Portfolios and Specifications
13.5.3 Amphastar Pharmaceuticals Inc. Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Amphastar Pharmaceuticals Inc. Main Business Overview
13.5.5 Amphastar Pharmaceuticals Inc. Latest Developments
13.6 Lilly USA, LLC
13.6.1 Lilly USA, LLC Company Information
13.6.2 Lilly USA, LLC Glucagon Injectable Product Portfolios and Specifications
13.6.3 Lilly USA, LLC Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Lilly USA, LLC Main Business Overview
13.6.5 Lilly USA, LLC Latest Developments
13.7 Zealand Pharma A/S.
13.7.1 Zealand Pharma A/S. Company Information
13.7.2 Zealand Pharma A/S. Glucagon Injectable Product Portfolios and Specifications
13.7.3 Zealand Pharma A/S. Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Zealand Pharma A/S. Main Business Overview
13.7.5 Zealand Pharma A/S. Latest Developments
13.8 Avalon Pharma Pvt. Ltd.
13.8.1 Avalon Pharma Pvt. Ltd. Company Information
13.8.2 Avalon Pharma Pvt. Ltd. Glucagon Injectable Product Portfolios and Specifications
13.8.3 Avalon Pharma Pvt. Ltd. Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Avalon Pharma Pvt. Ltd. Main Business Overview
13.8.5 Avalon Pharma Pvt. Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Glucagon Injectable Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Glucagon Injectable by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Glucagon Injectable by Country/Region, 2019, 2023 & 2030
2.2 Glucagon Injectable Segment by Type
2.2.1 Children
2.2.2 Adults
2.3 Glucagon Injectable Sales by Type
2.3.1 Global Glucagon Injectable Sales Market Share by Type (2019-2024)
2.3.2 Global Glucagon Injectable Revenue and Market Share by Type (2019-2024)
2.3.3 Global Glucagon Injectable Sale Price by Type (2019-2024)
2.4 Glucagon Injectable Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Others
2.5 Glucagon Injectable Sales by Application
2.5.1 Global Glucagon Injectable Sale Market Share by Application (2019-2024)
2.5.2 Global Glucagon Injectable Revenue and Market Share by Application (2019-2024)
2.5.3 Global Glucagon Injectable Sale Price by Application (2019-2024)
3 GLOBAL GLUCAGON INJECTABLE BY COMPANY
3.1 Global Glucagon Injectable Breakdown Data by Company
3.1.1 Global Glucagon Injectable Annual Sales by Company (2019-2024)
3.1.2 Global Glucagon Injectable Sales Market Share by Company (2019-2024)
3.2 Global Glucagon Injectable Annual Revenue by Company (2019-2024)
3.2.1 Global Glucagon Injectable Revenue by Company (2019-2024)
3.2.2 Global Glucagon Injectable Revenue Market Share by Company (2019-2024)
3.3 Global Glucagon Injectable Sale Price by Company
3.4 Key Manufacturers Glucagon Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glucagon Injectable Product Location Distribution
3.4.2 Players Glucagon Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GLUCAGON INJECTABLE BY GEOGRAPHIC REGION
4.1 World Historic Glucagon Injectable Market Size by Geographic Region (2019-2024)
4.1.1 Global Glucagon Injectable Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Glucagon Injectable Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Glucagon Injectable Market Size by Country/Region (2019-2024)
4.2.1 Global Glucagon Injectable Annual Sales by Country/Region (2019-2024)
4.2.2 Global Glucagon Injectable Annual Revenue by Country/Region (2019-2024)
4.3 Americas Glucagon Injectable Sales Growth
4.4 APAC Glucagon Injectable Sales Growth
4.5 Europe Glucagon Injectable Sales Growth
4.6 Middle East & Africa Glucagon Injectable Sales Growth
5 AMERICAS
5.1 Americas Glucagon Injectable Sales by Country
5.1.1 Americas Glucagon Injectable Sales by Country (2019-2024)
5.1.2 Americas Glucagon Injectable Revenue by Country (2019-2024)
5.2 Americas Glucagon Injectable Sales by Type
5.3 Americas Glucagon Injectable Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glucagon Injectable Sales by Region
6.1.1 APAC Glucagon Injectable Sales by Region (2019-2024)
6.1.2 APAC Glucagon Injectable Revenue by Region (2019-2024)
6.2 APAC Glucagon Injectable Sales by Type
6.3 APAC Glucagon Injectable Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Glucagon Injectable by Country
7.1.1 Europe Glucagon Injectable Sales by Country (2019-2024)
7.1.2 Europe Glucagon Injectable Revenue by Country (2019-2024)
7.2 Europe Glucagon Injectable Sales by Type
7.3 Europe Glucagon Injectable Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Glucagon Injectable by Country
8.1.1 Middle East & Africa Glucagon Injectable Sales by Country (2019-2024)
8.1.2 Middle East & Africa Glucagon Injectable Revenue by Country (2019-2024)
8.2 Middle East & Africa Glucagon Injectable Sales by Type
8.3 Middle East & Africa Glucagon Injectable Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glucagon Injectable
10.3 Manufacturing Process Analysis of Glucagon Injectable
10.4 Industry Chain Structure of Glucagon Injectable
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glucagon Injectable Distributors
11.3 Glucagon Injectable Customer
12 WORLD FORECAST REVIEW FOR GLUCAGON INJECTABLE BY GEOGRAPHIC REGION
12.1 Global Glucagon Injectable Market Size Forecast by Region
12.1.1 Global Glucagon Injectable Forecast by Region (2025-2030)
12.1.2 Global Glucagon Injectable Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glucagon Injectable Forecast by Type
12.7 Global Glucagon Injectable Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Fresenius SE & Co. KGaA
13.1.1 Fresenius SE & Co. KGaA Company Information
13.1.2 Fresenius SE & Co. KGaA Glucagon Injectable Product Portfolios and Specifications
13.1.3 Fresenius SE & Co. KGaA Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Fresenius SE & Co. KGaA Main Business Overview
13.1.5 Fresenius SE & Co. KGaA Latest Developments
13.2 Xeris Pharmaceuticals Inc
13.2.1 Xeris Pharmaceuticals Inc Company Information
13.2.2 Xeris Pharmaceuticals Inc Glucagon Injectable Product Portfolios and Specifications
13.2.3 Xeris Pharmaceuticals Inc Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Xeris Pharmaceuticals Inc Main Business Overview
13.2.5 Xeris Pharmaceuticals Inc Latest Developments
13.3 Novo Nordisk A/S
13.3.1 Novo Nordisk A/S Company Information
13.3.2 Novo Nordisk A/S Glucagon Injectable Product Portfolios and Specifications
13.3.3 Novo Nordisk A/S Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novo Nordisk A/S Main Business Overview
13.3.5 Novo Nordisk A/S Latest Developments
13.4 ILS.Inc
13.4.1 ILS.Inc Company Information
13.4.2 ILS.Inc Glucagon Injectable Product Portfolios and Specifications
13.4.3 ILS.Inc Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 ILS.Inc Main Business Overview
13.4.5 ILS.Inc Latest Developments
13.5 Amphastar Pharmaceuticals Inc.
13.5.1 Amphastar Pharmaceuticals Inc. Company Information
13.5.2 Amphastar Pharmaceuticals Inc. Glucagon Injectable Product Portfolios and Specifications
13.5.3 Amphastar Pharmaceuticals Inc. Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Amphastar Pharmaceuticals Inc. Main Business Overview
13.5.5 Amphastar Pharmaceuticals Inc. Latest Developments
13.6 Lilly USA, LLC
13.6.1 Lilly USA, LLC Company Information
13.6.2 Lilly USA, LLC Glucagon Injectable Product Portfolios and Specifications
13.6.3 Lilly USA, LLC Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Lilly USA, LLC Main Business Overview
13.6.5 Lilly USA, LLC Latest Developments
13.7 Zealand Pharma A/S.
13.7.1 Zealand Pharma A/S. Company Information
13.7.2 Zealand Pharma A/S. Glucagon Injectable Product Portfolios and Specifications
13.7.3 Zealand Pharma A/S. Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Zealand Pharma A/S. Main Business Overview
13.7.5 Zealand Pharma A/S. Latest Developments
13.8 Avalon Pharma Pvt. Ltd.
13.8.1 Avalon Pharma Pvt. Ltd. Company Information
13.8.2 Avalon Pharma Pvt. Ltd. Glucagon Injectable Product Portfolios and Specifications
13.8.3 Avalon Pharma Pvt. Ltd. Glucagon Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Avalon Pharma Pvt. Ltd. Main Business Overview
13.8.5 Avalon Pharma Pvt. Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Glucagon Injectable Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Glucagon Injectable Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Children
Table 4. Major Players of Adults
Table 5. Global Glucagon Injectable Sales by Type (2019-2024) & (K Units)
Table 6. Global Glucagon Injectable Sales Market Share by Type (2019-2024)
Table 7. Global Glucagon Injectable Revenue by Type (2019-2024) & ($ million)
Table 8. Global Glucagon Injectable Revenue Market Share by Type (2019-2024)
Table 9. Global Glucagon Injectable Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Glucagon Injectable Sales by Application (2019-2024) & (K Units)
Table 11. Global Glucagon Injectable Sales Market Share by Application (2019-2024)
Table 12. Global Glucagon Injectable Revenue by Application (2019-2024)
Table 13. Global Glucagon Injectable Revenue Market Share by Application (2019-2024)
Table 14. Global Glucagon Injectable Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Glucagon Injectable Sales by Company (2019-2024) & (K Units)
Table 16. Global Glucagon Injectable Sales Market Share by Company (2019-2024)
Table 17. Global Glucagon Injectable Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Glucagon Injectable Revenue Market Share by Company (2019-2024)
Table 19. Global Glucagon Injectable Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Glucagon Injectable Producing Area Distribution and Sales Area
Table 21. Players Glucagon Injectable Products Offered
Table 22. Glucagon Injectable Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Glucagon Injectable Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Glucagon Injectable Sales Market Share Geographic Region (2019-2024)
Table 27. Global Glucagon Injectable Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Glucagon Injectable Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Glucagon Injectable Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Glucagon Injectable Sales Market Share by Country/Region (2019-2024)
Table 31. Global Glucagon Injectable Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Glucagon Injectable Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Glucagon Injectable Sales by Country (2019-2024) & (K Units)
Table 34. Americas Glucagon Injectable Sales Market Share by Country (2019-2024)
Table 35. Americas Glucagon Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Glucagon Injectable Revenue Market Share by Country (2019-2024)
Table 37. Americas Glucagon Injectable Sales by Type (2019-2024) & (K Units)
Table 38. Americas Glucagon Injectable Sales by Application (2019-2024) & (K Units)
Table 39. APAC Glucagon Injectable Sales by Region (2019-2024) & (K Units)
Table 40. APAC Glucagon Injectable Sales Market Share by Region (2019-2024)
Table 41. APAC Glucagon Injectable Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Glucagon Injectable Revenue Market Share by Region (2019-2024)
Table 43. APAC Glucagon Injectable Sales by Type (2019-2024) & (K Units)
Table 44. APAC Glucagon Injectable Sales by Application (2019-2024) & (K Units)
Table 45. Europe Glucagon Injectable Sales by Country (2019-2024) & (K Units)
Table 46. Europe Glucagon Injectable Sales Market Share by Country (2019-2024)
Table 47. Europe Glucagon Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Glucagon Injectable Revenue Market Share by Country (2019-2024)
Table 49. Europe Glucagon Injectable Sales by Type (2019-2024) & (K Units)
Table 50. Europe Glucagon Injectable Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Glucagon Injectable Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Glucagon Injectable Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Glucagon Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Glucagon Injectable Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Glucagon Injectable Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Glucagon Injectable Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Glucagon Injectable
Table 58. Key Market Challenges & Risks of Glucagon Injectable
Table 59. Key Industry Trends of Glucagon Injectable
Table 60. Glucagon Injectable Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Glucagon Injectable Distributors List
Table 63. Glucagon Injectable Customer List
Table 64. Global Glucagon Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Glucagon Injectable Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Glucagon Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Glucagon Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Glucagon Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Glucagon Injectable Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Glucagon Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Glucagon Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Glucagon Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Glucagon Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Glucagon Injectable Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Glucagon Injectable Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Glucagon Injectable Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Glucagon Injectable Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Fresenius SE & Co. KGaA Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 79. Fresenius SE & Co. KGaA Glucagon Injectable Product Portfolios and Specifications
Table 80. Fresenius SE & Co. KGaA Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Fresenius SE & Co. KGaA Main Business
Table 82. Fresenius SE & Co. KGaA Latest Developments
Table 83. Xeris Pharmaceuticals Inc Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 84. Xeris Pharmaceuticals Inc Glucagon Injectable Product Portfolios and Specifications
Table 85. Xeris Pharmaceuticals Inc Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Xeris Pharmaceuticals Inc Main Business
Table 87. Xeris Pharmaceuticals Inc Latest Developments
Table 88. Novo Nordisk A/S Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 89. Novo Nordisk A/S Glucagon Injectable Product Portfolios and Specifications
Table 90. Novo Nordisk A/S Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Novo Nordisk A/S Main Business
Table 92. Novo Nordisk A/S Latest Developments
Table 93. ILS.Inc Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 94. ILS.Inc Glucagon Injectable Product Portfolios and Specifications
Table 95. ILS.Inc Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. ILS.Inc Main Business
Table 97. ILS.Inc Latest Developments
Table 98. Amphastar Pharmaceuticals Inc. Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 99. Amphastar Pharmaceuticals Inc. Glucagon Injectable Product Portfolios and Specifications
Table 100. Amphastar Pharmaceuticals Inc. Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Amphastar Pharmaceuticals Inc. Main Business
Table 102. Amphastar Pharmaceuticals Inc. Latest Developments
Table 103. Lilly USA, LLC Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 104. Lilly USA, LLC Glucagon Injectable Product Portfolios and Specifications
Table 105. Lilly USA, LLC Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Lilly USA, LLC Main Business
Table 107. Lilly USA, LLC Latest Developments
Table 108. Zealand Pharma A/S. Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 109. Zealand Pharma A/S. Glucagon Injectable Product Portfolios and Specifications
Table 110. Zealand Pharma A/S. Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Zealand Pharma A/S. Main Business
Table 112. Zealand Pharma A/S. Latest Developments
Table 113. Avalon Pharma Pvt. Ltd. Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 114. Avalon Pharma Pvt. Ltd. Glucagon Injectable Product Portfolios and Specifications
Table 115. Avalon Pharma Pvt. Ltd. Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Avalon Pharma Pvt. Ltd. Main Business
Table 117. Avalon Pharma Pvt. Ltd. Latest Developments
.
Table 1. Glucagon Injectable Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Glucagon Injectable Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Children
Table 4. Major Players of Adults
Table 5. Global Glucagon Injectable Sales by Type (2019-2024) & (K Units)
Table 6. Global Glucagon Injectable Sales Market Share by Type (2019-2024)
Table 7. Global Glucagon Injectable Revenue by Type (2019-2024) & ($ million)
Table 8. Global Glucagon Injectable Revenue Market Share by Type (2019-2024)
Table 9. Global Glucagon Injectable Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Glucagon Injectable Sales by Application (2019-2024) & (K Units)
Table 11. Global Glucagon Injectable Sales Market Share by Application (2019-2024)
Table 12. Global Glucagon Injectable Revenue by Application (2019-2024)
Table 13. Global Glucagon Injectable Revenue Market Share by Application (2019-2024)
Table 14. Global Glucagon Injectable Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Glucagon Injectable Sales by Company (2019-2024) & (K Units)
Table 16. Global Glucagon Injectable Sales Market Share by Company (2019-2024)
Table 17. Global Glucagon Injectable Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Glucagon Injectable Revenue Market Share by Company (2019-2024)
Table 19. Global Glucagon Injectable Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Glucagon Injectable Producing Area Distribution and Sales Area
Table 21. Players Glucagon Injectable Products Offered
Table 22. Glucagon Injectable Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Glucagon Injectable Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Glucagon Injectable Sales Market Share Geographic Region (2019-2024)
Table 27. Global Glucagon Injectable Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Glucagon Injectable Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Glucagon Injectable Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Glucagon Injectable Sales Market Share by Country/Region (2019-2024)
Table 31. Global Glucagon Injectable Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Glucagon Injectable Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Glucagon Injectable Sales by Country (2019-2024) & (K Units)
Table 34. Americas Glucagon Injectable Sales Market Share by Country (2019-2024)
Table 35. Americas Glucagon Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Glucagon Injectable Revenue Market Share by Country (2019-2024)
Table 37. Americas Glucagon Injectable Sales by Type (2019-2024) & (K Units)
Table 38. Americas Glucagon Injectable Sales by Application (2019-2024) & (K Units)
Table 39. APAC Glucagon Injectable Sales by Region (2019-2024) & (K Units)
Table 40. APAC Glucagon Injectable Sales Market Share by Region (2019-2024)
Table 41. APAC Glucagon Injectable Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Glucagon Injectable Revenue Market Share by Region (2019-2024)
Table 43. APAC Glucagon Injectable Sales by Type (2019-2024) & (K Units)
Table 44. APAC Glucagon Injectable Sales by Application (2019-2024) & (K Units)
Table 45. Europe Glucagon Injectable Sales by Country (2019-2024) & (K Units)
Table 46. Europe Glucagon Injectable Sales Market Share by Country (2019-2024)
Table 47. Europe Glucagon Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Glucagon Injectable Revenue Market Share by Country (2019-2024)
Table 49. Europe Glucagon Injectable Sales by Type (2019-2024) & (K Units)
Table 50. Europe Glucagon Injectable Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Glucagon Injectable Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Glucagon Injectable Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Glucagon Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Glucagon Injectable Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Glucagon Injectable Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Glucagon Injectable Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Glucagon Injectable
Table 58. Key Market Challenges & Risks of Glucagon Injectable
Table 59. Key Industry Trends of Glucagon Injectable
Table 60. Glucagon Injectable Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Glucagon Injectable Distributors List
Table 63. Glucagon Injectable Customer List
Table 64. Global Glucagon Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Glucagon Injectable Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Glucagon Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Glucagon Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Glucagon Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Glucagon Injectable Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Glucagon Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Glucagon Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Glucagon Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Glucagon Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Glucagon Injectable Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Glucagon Injectable Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Glucagon Injectable Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Glucagon Injectable Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Fresenius SE & Co. KGaA Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 79. Fresenius SE & Co. KGaA Glucagon Injectable Product Portfolios and Specifications
Table 80. Fresenius SE & Co. KGaA Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Fresenius SE & Co. KGaA Main Business
Table 82. Fresenius SE & Co. KGaA Latest Developments
Table 83. Xeris Pharmaceuticals Inc Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 84. Xeris Pharmaceuticals Inc Glucagon Injectable Product Portfolios and Specifications
Table 85. Xeris Pharmaceuticals Inc Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Xeris Pharmaceuticals Inc Main Business
Table 87. Xeris Pharmaceuticals Inc Latest Developments
Table 88. Novo Nordisk A/S Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 89. Novo Nordisk A/S Glucagon Injectable Product Portfolios and Specifications
Table 90. Novo Nordisk A/S Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Novo Nordisk A/S Main Business
Table 92. Novo Nordisk A/S Latest Developments
Table 93. ILS.Inc Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 94. ILS.Inc Glucagon Injectable Product Portfolios and Specifications
Table 95. ILS.Inc Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. ILS.Inc Main Business
Table 97. ILS.Inc Latest Developments
Table 98. Amphastar Pharmaceuticals Inc. Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 99. Amphastar Pharmaceuticals Inc. Glucagon Injectable Product Portfolios and Specifications
Table 100. Amphastar Pharmaceuticals Inc. Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Amphastar Pharmaceuticals Inc. Main Business
Table 102. Amphastar Pharmaceuticals Inc. Latest Developments
Table 103. Lilly USA, LLC Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 104. Lilly USA, LLC Glucagon Injectable Product Portfolios and Specifications
Table 105. Lilly USA, LLC Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Lilly USA, LLC Main Business
Table 107. Lilly USA, LLC Latest Developments
Table 108. Zealand Pharma A/S. Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 109. Zealand Pharma A/S. Glucagon Injectable Product Portfolios and Specifications
Table 110. Zealand Pharma A/S. Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Zealand Pharma A/S. Main Business
Table 112. Zealand Pharma A/S. Latest Developments
Table 113. Avalon Pharma Pvt. Ltd. Basic Information, Glucagon Injectable Manufacturing Base, Sales Area and Its Competitors
Table 114. Avalon Pharma Pvt. Ltd. Glucagon Injectable Product Portfolios and Specifications
Table 115. Avalon Pharma Pvt. Ltd. Glucagon Injectable Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Avalon Pharma Pvt. Ltd. Main Business
Table 117. Avalon Pharma Pvt. Ltd. Latest Developments
LIST OF FIGURES
.
Figure 1. Picture of Glucagon Injectable
Figure 2. Glucagon Injectable Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glucagon Injectable Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Glucagon Injectable Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Glucagon Injectable Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Children
Figure 10. Product Picture of Adults
Figure 11. Global Glucagon Injectable Sales Market Share by Type in 2023
Figure 12. Global Glucagon Injectable Revenue Market Share by Type (2019-2024)
Figure 13. Glucagon Injectable Consumed in Hospital Pharmacies
Figure 14. Global Glucagon Injectable Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 15. Glucagon Injectable Consumed in Retail Pharmacies
Figure 16. Global Glucagon Injectable Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 17. Glucagon Injectable Consumed in Online Pharmacies
Figure 18. Global Glucagon Injectable Market: Online Pharmacies (2019-2024) & (K Units)
Figure 19. Glucagon Injectable Consumed in Others
Figure 20. Global Glucagon Injectable Market: Others (2019-2024) & (K Units)
Figure 21. Global Glucagon Injectable Sales Market Share by Application (2023)
Figure 22. Global Glucagon Injectable Revenue Market Share by Application in 2023
Figure 23. Glucagon Injectable Sales Market by Company in 2023 (K Units)
Figure 24. Global Glucagon Injectable Sales Market Share by Company in 2023
Figure 25. Glucagon Injectable Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Glucagon Injectable Revenue Market Share by Company in 2023
Figure 27. Global Glucagon Injectable Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Glucagon Injectable Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Glucagon Injectable Sales 2019-2024 (K Units)
Figure 30. Americas Glucagon Injectable Revenue 2019-2024 ($ Millions)
Figure 31. APAC Glucagon Injectable Sales 2019-2024 (K Units)
Figure 32. APAC Glucagon Injectable Revenue 2019-2024 ($ Millions)
Figure 33. Europe Glucagon Injectable Sales 2019-2024 (K Units)
Figure 34. Europe Glucagon Injectable Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Glucagon Injectable Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Glucagon Injectable Revenue 2019-2024 ($ Millions)
Figure 37. Americas Glucagon Injectable Sales Market Share by Country in 2023
Figure 38. Americas Glucagon Injectable Revenue Market Share by Country in 2023
Figure 39. Americas Glucagon Injectable Sales Market Share by Type (2019-2024)
Figure 40. Americas Glucagon Injectable Sales Market Share by Application (2019-2024)
Figure 41. United States Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Glucagon Injectable Sales Market Share by Region in 2023
Figure 46. APAC Glucagon Injectable Revenue Market Share by Regions in 2023
Figure 47. APAC Glucagon Injectable Sales Market Share by Type (2019-2024)
Figure 48. APAC Glucagon Injectable Sales Market Share by Application (2019-2024)
Figure 49. China Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Glucagon Injectable Sales Market Share by Country in 2023
Figure 57. Europe Glucagon Injectable Revenue Market Share by Country in 2023
Figure 58. Europe Glucagon Injectable Sales Market Share by Type (2019-2024)
Figure 59. Europe Glucagon Injectable Sales Market Share by Application (2019-2024)
Figure 60. Germany Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Glucagon Injectable Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Glucagon Injectable Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Glucagon Injectable Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Glucagon Injectable Sales Market Share by Application (2019-2024)
Figure 69. Egypt Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Glucagon Injectable in 2023
Figure 75. Manufacturing Process Analysis of Glucagon Injectable
Figure 76. Industry Chain Structure of Glucagon Injectable
Figure 77. Channels of Distribution
Figure 78. Global Glucagon Injectable Sales Market Forecast by Region (2025-2030)
Figure 79. Global Glucagon Injectable Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Glucagon Injectable Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Glucagon Injectable Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Glucagon Injectable Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Glucagon Injectable Revenue Market Share Forecast by Application (2025-2030)
.
Figure 1. Picture of Glucagon Injectable
Figure 2. Glucagon Injectable Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glucagon Injectable Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Glucagon Injectable Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Glucagon Injectable Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Children
Figure 10. Product Picture of Adults
Figure 11. Global Glucagon Injectable Sales Market Share by Type in 2023
Figure 12. Global Glucagon Injectable Revenue Market Share by Type (2019-2024)
Figure 13. Glucagon Injectable Consumed in Hospital Pharmacies
Figure 14. Global Glucagon Injectable Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 15. Glucagon Injectable Consumed in Retail Pharmacies
Figure 16. Global Glucagon Injectable Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 17. Glucagon Injectable Consumed in Online Pharmacies
Figure 18. Global Glucagon Injectable Market: Online Pharmacies (2019-2024) & (K Units)
Figure 19. Glucagon Injectable Consumed in Others
Figure 20. Global Glucagon Injectable Market: Others (2019-2024) & (K Units)
Figure 21. Global Glucagon Injectable Sales Market Share by Application (2023)
Figure 22. Global Glucagon Injectable Revenue Market Share by Application in 2023
Figure 23. Glucagon Injectable Sales Market by Company in 2023 (K Units)
Figure 24. Global Glucagon Injectable Sales Market Share by Company in 2023
Figure 25. Glucagon Injectable Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Glucagon Injectable Revenue Market Share by Company in 2023
Figure 27. Global Glucagon Injectable Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Glucagon Injectable Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Glucagon Injectable Sales 2019-2024 (K Units)
Figure 30. Americas Glucagon Injectable Revenue 2019-2024 ($ Millions)
Figure 31. APAC Glucagon Injectable Sales 2019-2024 (K Units)
Figure 32. APAC Glucagon Injectable Revenue 2019-2024 ($ Millions)
Figure 33. Europe Glucagon Injectable Sales 2019-2024 (K Units)
Figure 34. Europe Glucagon Injectable Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Glucagon Injectable Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Glucagon Injectable Revenue 2019-2024 ($ Millions)
Figure 37. Americas Glucagon Injectable Sales Market Share by Country in 2023
Figure 38. Americas Glucagon Injectable Revenue Market Share by Country in 2023
Figure 39. Americas Glucagon Injectable Sales Market Share by Type (2019-2024)
Figure 40. Americas Glucagon Injectable Sales Market Share by Application (2019-2024)
Figure 41. United States Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Glucagon Injectable Sales Market Share by Region in 2023
Figure 46. APAC Glucagon Injectable Revenue Market Share by Regions in 2023
Figure 47. APAC Glucagon Injectable Sales Market Share by Type (2019-2024)
Figure 48. APAC Glucagon Injectable Sales Market Share by Application (2019-2024)
Figure 49. China Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Glucagon Injectable Sales Market Share by Country in 2023
Figure 57. Europe Glucagon Injectable Revenue Market Share by Country in 2023
Figure 58. Europe Glucagon Injectable Sales Market Share by Type (2019-2024)
Figure 59. Europe Glucagon Injectable Sales Market Share by Application (2019-2024)
Figure 60. Germany Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Glucagon Injectable Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Glucagon Injectable Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Glucagon Injectable Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Glucagon Injectable Sales Market Share by Application (2019-2024)
Figure 69. Egypt Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Glucagon Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Glucagon Injectable in 2023
Figure 75. Manufacturing Process Analysis of Glucagon Injectable
Figure 76. Industry Chain Structure of Glucagon Injectable
Figure 77. Channels of Distribution
Figure 78. Global Glucagon Injectable Sales Market Forecast by Region (2025-2030)
Figure 79. Global Glucagon Injectable Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Glucagon Injectable Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Glucagon Injectable Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Glucagon Injectable Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Glucagon Injectable Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Grasper Market Growth 2023-2029
US$ 3,660.00
March 2023
100 pages
Global Cord Blood Banking Services Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
November 2024
106 pages
Global Pediatric ECG Electrode Market Growth 2023-2029
US$ 3,660.00
February 2023
111 pages
Global Nanopore Sequencing Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
88 pages
